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The official analytical method of the Taiwan Food and Drug Administration, Ministry of
Health and Welfare for testing for veterinary drug residues in foods is the multiresidue
analysis of b-agonists. Samples are pretreated through liquideliquid extraction and solid-
phase extraction. This method is time consuming and requires the intensive use of sol-
vents. To improve analytical efficiency and reduce costs, our study incorporated QuEChERS
(Quick, Easy, Cheap, Effective, Rugged, and Safe) techniques to establish a new method of
multiresidue analysis of b-agonists in animal muscle and viscera. The pretreatment time
was shortened and solvent usage was minimized. The modified analysis was conducted
using liquid chromatography/tandem mass spectrometry (LCeMS/MS) and quantification
was performed using multiple reaction monitoring. The results demonstrated that the
correlation coefficients of the tissue calibration curve were higher than 0.99 and the limit of
quantification (LOQ) was 1 ppb. The average recoveries in spiked samples varied from 70%
to 120%, and the relative difference between duplicated analysis results was lower than
10%. On the basis of the results, the proposed method was concluded to be an appropriate
procedure for determining the presence of b-agonists, and demonstrated the advantages of
high recovery rates in spiked samples, high precision, reduced analysis time and solvent
usage, and lower costs.
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In recent years, the safety of meat products has been a source
of great public concern [1,2] and methods of detecting drug
residues have become a focus of researchworldwide. Effective
determinationmethods are required to guaranteemeat safety
[3,4]. Veterinary drugs are widely used at therapeutic levels in
livestock breeding systems for treating various diseases; one
type of these drugs, b-agonists, was originally intended to
treat asthma and preterm labor in humans [5]. However, these
compounds also promote lipolysis in muscle tissue and
exhibit a considerable nutrition redistribution function,
resulting in higher feed efficiency and a greater muscle-to-fat
ratio in livestock [6e8]. b-Agonists have been utilized in live-
stock such as pigs and ruminants to reduce carcass fat and
increase muscle mass, while improving the growth rate and
feed conversion [9e12]. Previous research indicated that the
residues of six b-agonists are prone to accumulate in the
retinal tissue of food-producing animals [13]. Moreover, the
ingestion of b-agonists deposited in animal tissues can cause
acute poisoning in humans, particularly in patients with
symptoms such as muscular tremors, cardiac palpitation,
nervousness, headaches, and muscular pain [14]. Tissues
contaminated with b-agonists appear to be harmful and pose
a potential risk to human health [15]. Although their use in the
therapeutic treatment of cattle with respiratory diseases is
permitted, the use of b-agonists as growth promoters in cattle
is forbidden in certain countries and the European Union [16].
However, illicit usage in animal feed persists in numerous
countries [17]. Sensitive and specific analytical methods are
therefore required to determine the level of b-agonists in
meat, in order to monitor food safety. These analytical
methods are essential for assessing human exposure to b-
agonists and supporting the enforcement of laws and
regulations.
A review of the literature shows that the methods used to
monitor b2-agonist residues include high-performance liquid
chromatography [18,19], gas chromatographyemass spec-
trometry [20,21], and liquid chromatographyemass spec-
trometry or liquid chromatographyetandem mass
spectrometry (LCeMS/MS) [22,23]. LCeMS/MS is currently
considered the most suitable technique used to detect multi-
ple classes of veterinary drugs in foodstuffs because it pro-
vides unambiguous identification and reliable confirmation
[24]. In order for a method to be deemed confirmatory, iden-
tification must be carried out according to relative retention
times, the identification points of each analyte, and the rela-
tive ion ratios of selected multiple reaction monitoring (MRM)
transitions. Despite the use of selective detection techniques
such as MS, appropriate sample preparation is a challenging
but necessary step in analytical procedures that reduces
interference and averts possible matrix effects. Techniques
such as immunoaffinity chromatography [25], liquideliquid
extraction [26], solid-phase extraction (SPE) [27], and matrix
SPE [28] are used for extraction and purification. Most of the
current extraction methods are time consuming and tedious.
Additionally, the general SPE cleanup techniques lack speci-
ficity and selectivity and can mix analytes and interferents.
This leads to interference and matrix effects and reduces thePlease cite this article in press as: Lin Y-P, et al., Determination of mul
chromatograph/tandem mass spectrometry with Quick, Easy, Cheap
Drug Analysis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.010reliability of determination. In addition, the large quantities of
organic solvents employed in these methods may cause
environmental pollution [29].
Consequently, analytical laboratories are increasingly
interested in developing new analytical methods that are
quicker and enable higher sample throughput. In 2003, the
QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe)
method for the multiclass and multiresidue analysis of pes-
ticides in fruits and vegetables was first published by Anas-
tassiades et al [30]. It has received widespread attention since
its development and expanded beyond its application in
traditional samples to include meat products, fish, blood, and
even soil. The QuEChERS method is now a widely known
methodology for the extraction of several classes of drugs,
including pesticides and veterinary drugs, from different
matrices. This method minimizes the time required for the
extraction and cleaning processes and reduces the sample
size, costs, required quantities of laboratory glassware, and
levels of solvent consumption [31]. Additionally, the estab-
lished QuEChERS pretreatment procedure without covering is
simple and economical and requires only small amounts of
organic solvents. This method can reduce the sample volume,
solvent consumption, and required analytical time. The
adaptation of the QuEChERS method for b-agonist monitoring
is therefore strongly recommended. The aim of this study was
to develop a rapid and easy multiresidue analytical method
involving the QuEChERS procedure to determine the levels of
seven b-agonists in muscle and viscera samples.2. Materials and methods
2.1. Samples
Samples (muscle and viscera) were purchased from local su-
permarkets and were confirmed to be free of the target drugs.
The tissues were homogenized and stored at 20C until
analysis was begun.
2.2. Chemicals, reagents, and solutions
All chemicals were of analytical grade. Acetonitrile, methanol
(high-performance liquid chromatography grade), and
ammonium acetate were obtained from Merck (Darmstadt,
Germany). Ultrapure water (Milli-Q, Millipore Corporation,
Bedford, MA, USA) was used to prepare all aqueous solutions.
All b-agonists (cimaterol, clenbuterol, ractopamine, salbu-
tamol, terbutaline, tulobuterol, and zilpaterol) and corre-
sponding internal standards (cimaterol-d7, clenbuterol-d9,
ractopamine-d6, clenbuterol-d9, salbutamol-d6, terbutaline-
d9, and zilpaterol-d7) were purchased from Sigma (St. Louis,
MO, USA). The minimum purity of all standards was 98.0%.
The chemical structures of all seven b-agonists are shown in
Figure 1.
2.3. Preparation of standards
Individual stock solutions (100 mg/mL) were prepared by dis-
solving 1 mg of each compound in 10 mL of methanol. These
were stored at 20C in brown glass to preventtiresidue analysis of b-agonists inmuscle and viscera using liquid
, Effective, Rugged, and Safe methodologies, Journal of Food and
Figure 1 e Chemical structures of the b-agonists in this study.
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tions of 1 mg/mL of each standard were prepared by mixing
100 mL of additives with each stock solution and diluting the
solution to 10 mL with methanol. The mixed standard solu-
tions were stored in amber bottles at 20C. Six mixed IS so-
lutions were prepared and stored in the same manner. All
working solutions and calibration standards were obtained
through gradient dilution of the intermediate solutions in
concentrations varying from 1 mg/mL to 1 ng/mL. A working
standard solution of ISs at a concentration of 1 mg/mL wasPlease cite this article in press as: Lin Y-P, et al., Determination of mul
chromatograph/tandem mass spectrometry with Quick, Easy, Cheap
Drug Analysis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.010determined with subsequent dilutions of their stock solutions
in methanol. When not in use, the working solutions were
kept at 20C and renewed weekly.
2.4. Sample preparation
Five grams of finely chopped muscle and viscera homogenates
was weighed into a 50 mL Falcon tube and spiked as appro-
priate with target compounds and the IS. Subsequently, 10 mL
of 0.2M sodiumacetate solutionwas added, and the tubesweretiresidue analysis of b-agonists inmuscle and viscera using liquid
, Effective, Rugged, and Safe methodologies, Journal of Food and
Table 1 e Gradient program of the mobile phase for HPLC
separation of the seven b-agonists in the present study
(flow rate 1 mL/min).
Time (min) 5 mM ammonium
acetate in methanol (%)
0 15
1 15
6 25
14 70
16 80
17 80
17.5 95
19.5 95
20 15
25 15
5 mM ammonium acetate in deionized water (%) þ 5 mM
ammonium acetate in methanol (%) ¼ 100
HPLC ¼ high performance liquid chromatography.
j o u r n a l o f f o o d and d ru g an a l y s i s x x x ( 2 0 1 6 ) 1e1 04shaken for 10 minutes. Following the addition of the IS and
100 mL of b-glucuronidase-arylsulfatase, the sample was incu-
bated in a 37C water bath for 1 hour before extraction. One
milliliter of 1% acetateeacetonitrile was added and themixture
was stirred in a shaker for 30 seconds. A ceramic homogenizer,
6 g of anhydrous magnesium sulfate, and 1.5 g of anhydrous
sodium acetate were then added and the tubes were shaken
vigorously for 1 minute. Following centrifugation at 4032  g
and 15C for 5 minutes, the supernatant was transferred to a
new tube containing 900 mg of anhydrous magnesium sulfate,
150 mg of primary secondary amine (PSA), and C18EC and then
subjected to high-speed homogenization for 1 minute and a
second round of centrifugation under the same conditions. The
supernatant was evaporated to dryness by a nitrogen blowing
concentrator in a water bath at 65C. The muscle and viscera
residues were redissolved with 1 mL of an acetonitrileeH2O
solution (9:1, v/v) and acetonitrile, respectively. The sample
extract was filtered through a 0.22-mm polytetrafluoroethylene
filter into an autosampler vial for the LCMS/MS analysis. AFigure 2 e Diagram of sample preparation.
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j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e1 0 5scheme diagram of this sample preparation is shown in
Figure 2.2.5. LCeMS/MS analysis
LC was performed on a Dionex Ultimate 3000 Rs system (Sun-
nyvale, CA, USA) coupled to an AB SCIEX Q TRAP 5500 mass
spectrometer (Framingham, MA, USA). Chromatographic sep-
arationwas performed using an Agilent Zorbox SB-C18 column
(150 mm  4.6 mm, 5 mm, Palo Alto, CA, USA). Linear gradient
elution was performed as shown in Table 1. The injection vol-
ume was 10 mL. Mass analysis was carried out using an elec-
trospray ionization source in positive mode. The operation
conditions were as follows: ionspray voltage, 5.5 kV; source
temperature, 650

C; curtain gas, 20 psi; ion source gases 1 and 2,
65psi.TheoptimalMRMparameters are summarized inTable2.2.6. Method validation
For the method validation, various parameters such as line-
arity, accuracy, precision, and limits of quantification (LOQs)
were evaluated. The peak area of the most intense transition
versus the concentration was used to establish the linear
regression equation. The linearity of the method was evalu-
ated on the basis of tissue calibration.
2.6.1. Linearity
Tissue calibration curves were used to quantify and test the
linearity of the developed method. The blank muscle and
viscera sampleswere fortified at five concentrations of 1e50 mg/
kg of the target analytes. Three replications of each concen-
tration were performed. Sample preparation was executed ac-
cording to the aforementioned procedures. The tissue
calibration curves for b-agonists were constructed by calcu-
lating the ratio of each peak area relative to the corresponding
IS. The linearity of the LCeMS/MSmethodwas evaluated using
the regression coefficient measured for each analyte. The
acceptance criterion was a correlation coefficient (R2) >0.99.
2.6.2. Accuracy and precision
The results for accuracy and precision were expressed as the
percentage of recovery and the coefficient of variation (CV). Re-
covery and repeatability were assessed by spiking blankmuscle
and viscera samples at two concentration levels (1.5 mg/kg and
3.0 mg/kg) for target analytes in five replicates at each level.Table 2 e Parameters of MRM condition and retention times o
Compound ESI Retention time
(min)
Precursor ion
(m/z)
Produc
(m/
Cimaterol þ 4.40 220 202,
Clenbuterol þ 7.62 277 203,
Ractopamine þ 6.34 320.01 284,
Salbutamol þ 4.53 240.01 148,
Terbutaline þ 4.45 226 152,
Tulobuterol þ 8.48 228 154,
Zilpaterol þ 4.70 262.2 244,
ESI ¼ electrospray ionization; MRM ¼multiple reaction monitoring.
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LOQs were calculated by analyzing blank samples fortified at
1.0 mg/kg and defined as the lowest concentration of an ana-
lyte for which the signal-to-noise ratio was >10.3. Results and discussion
3.1. Optimization of LCeMS/MS parameters
The LCeMS/MS method was developed to provide confir-
matory data for the analysis of seven b-agonists in animal
muscle and viscera tissue. Separation was performed in an
Agilent Zorbox SB-C18 column (150 mm  4.6 mm, 5 mm).
Chromatographic parameters such as the choice of column,
mobile phase composition, gradient conditions, and flow rate
were tested to obtain the optimal separation of b-agonists.
With reference to previous reports, amobile phase consisting
of 5 mM ammonium acetate in water and methanol was
chosen [32e34]. The addition of ammonium acetate greatly
improved peak shape and facilitated resolving closely eluted
compounds. After optimization, the ammonium acetate
concentration was set at 5 mM, and its addition to the
aqueous phase further improved separation and overall peak
shapes [8]. b-Agonists belong to Group A of Annex I, Council
Directive 96/23/EC [35], therefore a minimum of four identi-
fication points are required, and were obtained by moni-
toring one parent ion (1 point) and two transitions (1.5 points
each). The product ion with the stronger signal was selected
as the ion for quantification, and the product ion with the
weaker signal was selected as the ion for identification. The
selected transitions for b-agonists and the optimal MSeMS
conditions are described in Section 2.6. The gradient program
in Table 1 was used for chromatographic separation. The
flow rate was set at 1.0 mL/min and the analysis was
completed in 25 minutes for the seven b-agonists. The MRM
chromatograms of the seven b-agonists in the present study
are shown in Figure 3.3.2. Optimization of sample preparation
Sample preparation plays an important role in analytical
methods. Various pretreatment methods have been proposed
formonitoring the illegal use of b-agonists [25,26,36]. Salts and
endogenous compounds cannot be fully removed due to thef the b-agonists.
t ions
z)
Decluster
potential
(V)
Entrance
potential
(V)
Collision
energy
(eV)
Collision cell
exit potential
(V)
160 45 10 12, 10 13
259 58 10 20,15 13
107 59 10 18, 33 13
222 45 10 24, 13 13
125 60 10 20, 32 13
118 40 10 22, 33 13
185 54 10 19, 33 13
tiresidue analysis of b-agonists inmuscle and viscera using liquid
, Effective, Rugged, and Safe methodologies, Journal of Food and
Figure 3 e Extract chromatograms of the seven b-agonists spiked at 3.0 mg/kg in muscle samples.
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Table 4 e Recovery rates and CVs of the b-agonists from
muscle samples.
b-Agonists Spiked level (ng/g) Recovery (%) CV (%)
Cimaterol 1.5 90.5 5.4
3.0 95.1 3.1
Clenbuterol 1.5 99.2 1.7
3.0 87.6 5.8
Ractopamine 1.5 98.5 4.3
3.0 100.3 4.6
Salbutamol 1.5 101.2 4.2
3.0 90.8 5.8
Terbutaline 1.5 96.3 6.3
3.0 100.2 3.5
Tulobuterol 1.5 97.9 7.7
3.0 102.5 3.2
Zilpaterol 1.5 94.4 3.2
3.0 97.4 6.4
CV ¼ coefficient of variation.
Table 5 e Recovery rates and CVs of the b-agonists from
viscera samples.
b-Agonists Spiked level (ng/g) Recovery (%) CV (%)
Cimaterol 1.5 102.0 3.2
3.0 95.0 4.2
Clenbuterol 1.5 101.1 2.5
3.0 102.1 2.1
Ractopamine 1.5 99.6 5.7
3.0 103.6 3.6
Salbutamol 1.5 110.3 4.2
3.0 106.9 3.4
Terbutaline 1.5 100.8 4.2
3.0 111.5 2.9
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e1 0 7complexity of the biological matrices and the trace levels in
real samples, leading to possible matrix effects. In addition,
these techniques are time consuming, and the large quantities
of organic solvents required, including acetonitrile and
methanol [2,29], may cause environmental pollution. By
contrast, the established QuEChERS pretreatment procedure
without covering is simple and economical and requires only
small amounts of organic solvents. The principle of the
QuEChERS method relies on sample cleaning using various
dispersive SPE sorbents, including PSA, C18, and silica, as well
as magnesium sulfate for the elimination of residual water
prior to analysis [37]. To improve efficiency and reduce time-
consuming sample preparation, the QuEChERS method was
developed for the cleaning of target analytes in tissue extracts.
The procedure begins with sodium acetate buffer solution
extraction and enzymatic hydrolysis. Previous studies have
demonstrated that favorable recoveries were obtained for
most compounds when acetonitrile acidified with 1% acetic
acid was used as the extraction solvent [38]. In this work,
10 mL of acetonitrile acidified with 1% acetic acid was used as
the extraction solvent. While the analytes are transferred to
an organic phase, some polar matrix impurities are left in the
aqueous layer. A combination of 1.5 g sodium acetate and 6 g
magnesium sulfate was used as a salting-out agent to parti-
tion analyte residues into the acetonitrile layer. Several sor-
bents such as PSA and C18 enabled satisfactory analyte
recovery. The muscle and viscera extracts were evaporated
under a stream of nitrogen at 65C and the final residue was
dissolved in 1mL of an acetonitrileeH2O solution (9:1, v/v) and
acetonitrile, respectively. The optimized sample preparation
protocol enabled a high percentage of recovery for the seven
b-agonists.
Tulobuterol 1.5 102.4 1.8
3.0 105.5 6.2
Zilpaterol 1.5 90.7 6.6
3.0 91.7 6.9
CV ¼ coefficient of variation.3.3. Method validation
3.3.1. Linearity
The linearity of the analytical method was validated using
the tissue calibration curves for each compound at different
concentration levels to prevent matrix effects. Table 3
shows the tissue calibration parameters of the correlation
coefficients. Table 3 shows R2 > 0.99 for all seven b-agonists
in muscle and viscera samples, which revealed good line-
arity in the concentration range for each b-agonist.Table 3 e Linearity and LOQs of the b-agonists.
b-Agonists Muscle Viscera
R2 LOQ (ng/g) R2 LOQ (ng/g)
Cimaterol 0.998 1 0.997 1
Clenbuterol 1.000 1 0.999 1
Ractopamine 0.998 1 0.997 1
Salbutamol 0.998 1 0.995 1
Terbutaline 0.996 1 0.995 1
Tulobuterol 0.999 1 0.998 1
Zilpaterol 0.993 1 0.993 1
LOQ ¼ limit of quantification.
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The rates of recovery of each compound from muscle and
viscera samples were evaluated at two concentration levels
(1.5 mg/kg and 3.0 mg/kg) by determining the ratios of the
measured and added amounts of the target analyte. The re-
sults of the recovery test for the seven b-agonists in muscle
and viscera samples are listed in Tables 4 and 5. In muscle
samples, the recovery rate of the 1.5 mg/kg and 3.0 mg/kg
spiking levels ranged from 90.5% to 101.2% and 87.6% to
102.5%, respectively. In viscera samples, the recovery rate of
the two spiking levels varied from 90.7% to 110.3% and 91.7%
to 111.5%, respectively. These results showed that the accu-
racy of this method was satisfactory.
3.3.3. Precision
The precision of the assay was assessed at 1.5 mg/kg and
3.0 mg/kg for each analyte in the spiked samples and
expressed as the CV. The results are presented in Tables 4 and
5. The CV of themuscle samples spiked at 1.5 mg/kg and 3.0 mg/
kg ranged from 1.7% to 7.7% and 3.1% to 6.4%, respectively,
and the corresponding values for the viscera samples variedtiresidue analysis of b-agonists inmuscle and viscera using liquid
, Effective, Rugged, and Safe methodologies, Journal of Food and
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Drug Analysis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.010from 1.8% to 6.6% and 2.1% to 6.9%, respectively. Thus, all CV
values were less than 10% at the two concentrations (1.5 mg/kg
and 3.0 mg/kg).
3.3.4. LOQ
The LOQ was defined as the concentration at 10 times the
signal intensity of noise. The LOQs of all b-agonists were
1.0 mg/kg for the spiked muscle and viscera sample. The LOQs
of this method are generally more favorable than those of
some traditional methods, but the LOQs obtained in the cur-
rent study are equal to or less favorable than those of other
methods. Nevertheless, very low LOQs were achieved for
spiked muscle and viscera samples. These results clearly
demonstrate the feasibility of the proposed method. The
method ensured reliable preparation and precise quantifica-
tion of seven b-agonists. This comparison is shown in Table 6
[8,16,18,25,38e46].4. Conclusion
In the present study, a simple, fast, and sensitivemultiresidue
analytical method involving LCeMS/MS was developed and
validated for the simultaneous determination of seven b-ag-
onists from two types of animal tissue (muscle and viscera).
Analytes were extracted using the QuEChERS extraction pro-
cedure and analyzed using LC electrospray ionization MS/MS.
This method was validated with fortified blank samples and
the extraction procedure was fully optimized. Favorable
values of validation parameters such as linearity, recovery,
precision, and LOQs were obtained, indicating the suitability
of the proposed solvent extraction method for the analysis of
b-agonists. The proposed method possesses the following
advantages: simplicity, speed, reliability, low cost, and low
solvent consumption. QuEChERS is therefore a green tech-
nique for sample preparation.Conflicts of interest
The authors certify that they have no conflicts of interest with
any financial organization regarding thematerial discussed in
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